Associate Chief of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School.

 

Dr Sands received his MD from the University of Cincinnati in 2005.

He completed his residency in internal medicine at the University of California, Davis and fellowship training in hematology/oncology also at the University of California, Davis.

He joined the faculty in the Lowe Center for Thoracic Oncology at Dana-Farber in 2017 and is the Associate Chief.

His research focuses on improved diagnostics and treatments for lung cancer and is a co-founder and President of the Rescue Lung Society, a non-profit medical society focused on advancing lung screening.

Dr Jacob Sands has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Consulting: Abbvie, Amgen, AstraZeneca, Boehringer Ingleheim, Catalyst, Daiichi Sankyo, Fosun, Genetech, Gilead, Jazz Pharmaceuticals, Lilly, Merck, Novartis, Pfizer, Pharma Mar, Sanofi 

 

Research to institution: Amgen, Novartis